The future availability of more specific markers for microglial activation and neuroinflammation (63, 64, 65, 66, 67, 68, 69, 70), to be used in place of or in parallel to TSPO ligands, will substantially help the interpretation of future results in the area of neuroinflammation and depression. This evidence concerns the gene TSPO and depressive disorder.